Clinical Trials Browser

Phase 1/2 × Recruiting × Peritoneal Neoplasms × Clear all

NCT05700656 2024-07-22

Galunisertib Combined With Capecitabine in Advanced CRC With PM

Phase 1/2 Recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms